Ep 1: Breaking the Cycle of HFpEF and Atrial Fibrillation
Ep 1: Breaking the Cycle of Heart Failure With Preserved Ejection Fraction and Atrial Fibrillation

Average (ratings)
No ratings
 
  Your rating

In this episode of the Radcliffe Cardiology Podcast, Dr Otilia Tica (University of Medicine of Oradea, Oradea, RO) is joined by Patient Representative, Mary Stanbury to outline ways in which cardiologists can break the cycle of heart failure with preserved ejection fraction (HFpEF) and atrial fibrillation (AF). This discussion is centered around a recently published article authored by Dr Tica in CFR Journal, 'Breaking the Cycle of Heart Failure With Preserved Ejection Fraction and Atrial Fibrillation'. [https://www.cfrjournal.com/articles/breaking-cycle-heart-failure-preserved-ejection-fraction-and-atrial-fibrillation]

In this episode, key discussion topics include: - Diagnosis, treatment and patient wellbeing for comorbid HFpEF and AF - Adverse event rates and prognostic implications for HFpEF and AF, and how we can close the gaps in the diagnostic challenges - Approaches and critical steps to patient management.

Prefer to watch in video format? Click here.
If you have any questions or suggestions, please email managingeditor@ecrjournal.com.


Read MoreRead Less
Share
Up Next
View from the Thoraxcenter: What's Hot at ACC.23?
EP22 • Feb 24, 2023 • 22m 4s
In this episode of "View from the Thoraxcenter," Prof Nicolas Van Mieghem and Dr Joost Daemen preview the most anticipated late-breaking and featured science trials of ACC.23 and discuss their potential impact on patient care and research.
Read More
All Episodes
Targeting Inflammation in Atherosclerosis: Inflammation and Atherosclerosis
EP13 • May 13, 2022 • 8m 39s
Inflammation and Atherosclerosis – What is the Link with CKD? Join Prof Juan Carlos Kaski (St George’s University of London, UK) and Prof Lina Badimon (Hospital of Santa Creu and San Pau, Barcelona, Spain) as they discuss that very question.
Read More
Targeting Inflammation in Atherosclerosis: Therapeutic Targets and Mode of Action
EP12 • May 16, 2022 • 6m 42s
Prof Juan Carlos Kaski (St George’s University of London, UK) alongside Dr Peter Libby (Brigham and Women’s Hospital, Boston, US) provide us with a short and concise discussion regarding Therapeutic Targets and Mode of Action.
Read More
Targeting Inflammation in Atherosclerosis: Inflammatory Signalling in Atherosclerosis and CKD
EP11 • May 13, 2022 • 8m 36s
Inflammatory Signalling in Atherosclerosis and CKD is the topic of interest in this short peer to peer discussion involving Prof Juan Carlos Kaski (St George’s University of London, UK) and Prof Paul Ridker (Brigham and Women’s Hospital, Boston, US).

Supported by an unrestricted educational grant from NOVO NORDISK A/S.
Read More
Targeting Inflammation in Atherosclerosis: Unmet Clinical Needs in Atherosclerosis and Chronic Kidney Disease
EP10 • May 13, 2022 • 9m 50s
Prof Juan Carlos Kaski (St George’s University of London, UK) is joined by Prof Paul Ridker (Brigham and Women’s Hospital, Boston, US) to discuss Unmet Clinical Needs in Atherosclerosis and Chronic Kidney Disease where they cover topics such as elevated hsCRP and chronic kidney disease.
Read More
Targeting Inflammation in Atherosclerosis: COLCOT Trial
EP9 • Apr 22, 2022 • 5m 13s
Prof Jean-Claude Tardif (Montreal Heart Institute, Canada) gives us a comprehensive overview of the COLCOT trial.
Read More
Targeting Inflammation in Atherosclerosis: LoDoCo2 Trial
EP8 • Apr 22, 2022 • 5m 3s
In this LoDoCo2 presentation, Dr Aernoud Fiolet (University Medical Center Utrecht, Netherlands) covers the trial design and main results.

Supported by an unrestricted educational grant from NOVO NORDISK A/S.

Read More
Targeting Inflammation in Atherosclerosis: RESCUE Trial
EP7 • Apr 12, 2022 • 4m 22s
Join Dr Peter Libby (Brigham and Women’s Hospital, Boston, US) as he talks us through the RESCUE trial design and results in this short podcast.
Read More
Targeting Inflammation in Atherosclerosis: CANTOS Trial
EP6 • Apr 12, 2022 • 6m 19s
Prof Paul Ridker (Brigham and Women’s Hospital, Boston, US) provides us with an overview of the CANTOS main trial results and updated results from the ACC 2022.
Read More
Ep 5: Invasive Diagnosis of Coronary Functional Disorder
EP5 • Mar 25, 2022 • 29m 28s
Did you know that coronary vasomotion disorders are a frequent cause of angina in patients with non-obstructed coronary arteries? In this month's episode of the ECR podcast, Dr Andreas Seitz and Dr Peter Ong (Robert-Bosch Hospital, Stuttgart, DE) return to discuss their recent article on the diagnosis of coronary disorders which cause angina (https://www.ecrjournal.com/articles/invasive-diagnosis-coronary-functional-disorders-causing-angina-pectoris) from ECR Journal.
Read More
Ep 4: The EXCEL Trial: The Interventionalists’ Perspective
EP4 • Jan 28, 2022 • 12m 40s
In this month's featured author episode of the ECR Podcast, interventional fellow Dr George Hunter (Bedfordshire Hospitals NHS Foundation Trust, Bedford, UK) discusses the EXCEL trial from his perspective as a member of the PCI community, based on a recent review paper from the ECR Journal. In this podcast, Dr Hunter discusses the controversy surrounding the trial and the importance of studying left main stem disease in cardiology today.
Read More
Ep 9: Sex Differences in Hypertension: Pharmacological Treatment
EP18 • Oct 31, 2022 • 25m 38s
In the first of a three-part ECR Podcast series on hypertension in women, Dr Isabella Sudano (University Hospital and University of Zurich, Zurich, CH) and Dr Eva Gerdts (Haukeland University Hospital, Bergen, NO) are joined by Prof Juan Tamargo (University Complutense, Madrid, ES) to discuss pharmalogical treatment options and considerations. 
Read More
Ep 8: The Role of CT Coronary Angiography in Chronic Total Occlusion Intervention
EP17 • Sep 30, 2022 • 23m 47s
What considerations must be made when screening chronic total occlusion patients undergoing PCI, and how can CT be used in daily practice?

In this month's episode of ECR Podcast, Dr Vinoda Sharma, (Sandwell and West Birmingham Hospitals NHS Trust, Birmingham, UK) and Dr Abdul Mozid, (Leeds Teaching Hospitals NHS Trust, Leeds, UK) discuss the ways in which CT coronary angiography can be utilised in chronic total occlusion percutaneous coronary interventions, and how the procedures differ across their UK-based practices.
Read More
Ep 7: Socioeconomic Factors Impacting Coronary and Structural Intervention
EP16 • Sep 12, 2022 • 26m 25s
What are the social factors that impact access to coronary and structural intervention in the current landscape of cardiology? In this month's episode of ECR Podcast, guest editor of ECR's special focus on gender disparities in interventional and structural heart procedures, Dr Natalia Berry (Mid Atlantic Permanente Medical Group, Washington DC, USA) is joined by Dr Renee Bullock-Palmer, (Deborah Heart and Lung Center, Pemberton, NJ, USA) to answer some of these questions.
Read More
Ep 6: Inflammatory Biomarkers and Cardiovascular Risk
EP15 • Jun 29, 2022 • 28m 46s
What are the clinical challenges in the use of biomarkers to estimate the risk of a cardiovascular event?
Read More
Targeting Inflammation in Atherosclerosis: Current Guidelines and Clinical Data
EP14 • May 16, 2022 • 7m 25s
Join Prof Juan Carlos Kaski (St George’s University of London, UK) and Dr Aernoud Fiolet (University Medical Center Utrecht, Netherlands) as they explore topics such as how guidelines currently view anti-inflammatory approaches and main molecules under investigation.

Supported by an unrestricted educational grant from NOVO NORDISK A/S.
Read More